Comparison of bromfenac 0.09% QD to nepafenac 0.1% TID after cataract surgery: pilot evaluation of visual acuity, macular volume, and retinal thickness at a single site

References

• CongdonNVingerlingJRKleinBEPrevalence of cataract and pseudophakia/aphakia among adults in the United StatesArch Ophthalmol2004122448749415078665
   PubMedGoogle Scholar
• DesaiPMinassianDCReidyANational cataract surgery survey 1997–1998: a report of the results of the clinical outcomesBr J Ophthalmol199983121336134010574810
   PubMed Web of Science ®Google Scholar
• MangioneCMPhillipsRSLawrenceMGSeddonJMOravEJGoldmanLImproved visual function and attenuation of declines in health-related quality of life after cataract extractionArch Ophthalmol199411211141914257980131
   PubMedGoogle Scholar
• McGwinGJrScilleyKBrownJOwsleyCImpact of cataract surgery on self-reported visual difficulties: comparison with a no-surgery reference groupJ Cataract Refract Surg200329594194812781280
   PubMed Web of Science ®Google Scholar
• ScheinODSteinbergEPJavittJCVariation in cataract surgery practice and clinical outcomesOphthalmology19941016114211528008356
   PubMed Web of Science ®Google Scholar
• O’BrienTPEmerging guidelines for use of NSAID therapy to optimize cataract surgery patient careCurr Med Res Opin20052171131113716004683
   PubMed Web of Science ®Google Scholar
• WolfEJBraunsteinAShihCBraunsteinREIncidence of visually significant pseudophakic macular edema after uneventful phacoemulsification in patients treated with nepafenacJ Cataract Refract Surg20073391546154917720068
   PubMed Web of Science ®Google Scholar
• KimSJFlachAJJampolLMNonsteroidal anti-inflammatory drugs in ophthalmologySurv Ophthalmol201055210813320159228
   PubMed Web of Science ®Google Scholar
• FlachAJTopical nonsteroidal antiinflammatory drugs in ophthalmologyInt Ophthalmol Clin200242111112189605
   PubMedGoogle Scholar
• SamiyNFosterCSThe role of nonsteroidal antiinflammatory drugs in ocular inflammationInt Ophthalmol Clin19963611952068778065
   PubMedGoogle Scholar
• SchalnusRTopical nonsteroidal anti-inflammatory therapy in ophthalmologyOphthalmologica20032172899812592044
   PubMed Web of Science ®Google Scholar
• LoboCLFariaPMSoaresMABernardesRCCunha-VazJGMacular alterations after small-incision cataract surgeryJ Cataract Refract Surg200430475276015093635
   PubMed Web of Science ®Google Scholar
• McColginAZHeierJSControl of intraocular inflammation associated with cataract surgeryCurr Opin Ophthalmol20001113610724825
   PubMedGoogle Scholar
• SourdillePSantiagoPYOptical coherence tomography of macular thickness after cataract surgeryJ Cataract Refract Surg19992522562619951674
   PubMed Web of Science ®Google Scholar
• WittpennJRSilversteinSHeierJA randomized, masked comparison of topical ketorolac 0.4% plus steroid vs steroid alone in low-risk cataract surgery patientsAm J Ophthalmol2008146455456018599019
   PubMed Web of Science ®Google Scholar
• BlumenkranzMSHallerJAKuppermannBDCorrelation of visual acuity and macular thickness measured by optical coherence tomography in patients with persistent macular edemaRetina20103071090109420616686
   PubMed Web of Science ®Google Scholar
• FlachAJThe incidence, pathogenesis and treatment of cystoid macular edema following cataract surgeryTrans Am Ophthalmol Soc19989655763410360304
   PubMedGoogle Scholar
• KidaTOgawaTMcNamaraTRSongCKGowJAEvaluations of the human COX-2 inhibition for amfenac, bromfenac, diclofenac, and ketorolacPaper presented at: American Society of Cataract and Refractive Surgery Symposium on Cataract, IOL, and Refractive SurgeryApril 27–May 2, 2007San Diego, CA
   Google Scholar
• GamacheDAGraffGBradyMTSpellmanJMYanniJMNepafenac, a unique nonsteroidal prodrug with potential utility in the treatment of trauma-induced ocular inflammation: I. Assessment of anti-inflammatory efficacyInflammation200024435737010850857
   PubMed Web of Science ®Google Scholar
• BucciFAJrWaterburyLDProstaglandin E2 inhibition of ketorolac 0.45%, bromfenac 0.09%, and nepafenac 0.1% in patients undergoing phacoemulsificationAdv Ther201128121089109522105509
   PubMed Web of Science ®Google Scholar
• DonnenfeldEDHollandEJStewartRHBromfenac ophthalmic solution 0.09% (Xibrom) for postoperative ocular pain and inflammationOphthalmology200711491653166217445902
   PubMed Web of Science ®Google Scholar
• SilversteinSMCableMGSadriEOnce daily dosing of bromfenac ophthalmic solution 0.09% for postoperative ocular inflammation and painCurr Med Res Opin20112791693170321751945
   PubMed Web of Science ®Google Scholar
• NardiMLoboCBereczkiAAnalgesic and anti-inflammatory effectiveness of nepafenac 0.1% for cataract surgeryClin Ophthalmol20071452753319668532
   PubMedGoogle Scholar
• LaneSSModiSSLehmannRPHollandEJNepafenac ophthalmic suspension 0.1% for the prevention and treatment of ocular inflammation associated with cataract surgeryJ Cataract Refract Surg2007331535817189793
   PubMed Web of Science ®Google Scholar
• WaltersTRaizmanMErnestPGaytonJLehmannRIn vivo pharmacokinetics and in vitro pharmacodynamics of nepafenac, amfenac, ketorolac, and bromfenacJ Cataract Refract Surg20073391539154517720067
   PubMed Web of Science ®Google Scholar
• BucciFJrWaterburyLDComparison of ketorolac 0.4% and bromfenac 0.09% at trough dosing: aqueous drug absorption and prostaglandin E2 levelsJ Cataract Refract Surg20083491509151218721711
   PubMed Web of Science ®Google Scholar
• KawaguchiTKidaTNemotoSEffect of bromfenac ophthalmic solution on ocular inflammation and corneal epithelial barrier function following cataract surgeryNihon Ganka Kiyo2003544276279 Japanese
   Google Scholar
• Bromday^™ (bromfenac ophthalmic solution) 0.09% [package insert]Irvine, CAISTA Pharmaceuticals Inc2011
   Google Scholar
• Nevanac^® (nepafenac ophthalmic suspension) 0.1% [package insert]Fort Worth, TXAlcon Laboratories Inc2011
   Google Scholar
• MiyakeKMasudaKShiratoSComparison of diclofenac and fluorometholone in preventing cystoid macular edema after small incision cataract surgery: a multicentered prospective trialJpn J Ophthalmol2000441586710698027
   PubMed Web of Science ®Google Scholar
• PerenteIUtineCAOzturkerCEvaluation of macular changes after uncomplicated phacoemulsification surgery by optical coherence tomographyCurr Eye Res200732324124717453944
   PubMed Web of Science ®Google Scholar
• BiroZBallaZKovacsBChange of foveal and perifoveal thickness measured by OCT after phacoemulsification and IOL implantationEye (Lond)200822181216751754
   PubMed Web of Science ®Google Scholar